Literature DB >> 33603587

Valproate-Induced Hyperammonemic Encephalopathy Following Accidental Ingestion in a Toddler.

Moftah Alhagamhmad, Aisha Elarwah, Alia Alhassony, Shirin Alougly, Hamza Milad, Aziza Dehoam, Suliman Elbrgathy, Nuri Shembesh, Emhemed Mousa, Abdulhamid ElShiky.   

Abstract

Clinical manifestations of valproic acid (VPA) toxicity can range from just mild confusion and drowsiness to serious encephalopathy, leading to depressed sensorium and even coma and death. The exact cause(s) of how VPA influences the integrity of brain function remains unknown. Nevertheless, several mechanisms have been postulated including a surge in the blood ammonia concentration. Valproic acid-induced hyperammonemic encephalopathy is a rare yet serious sequalae and that can lead to grave outcomes. We report a case of hyperammonemic encephalopathy with preserved liver function following a moderate VPA intoxication in a toddler, who was successfully managed conservatively. Additionally, we briefly discuss mechanistic basis of VPA toxicity and highlight some of the available potential therapies. Copyright. Pediatric Pharmacy Association. All rights reserved. For permissions, email: mhelms@pediatricpharmacy.org 2021.

Entities:  

Keywords:  accidental ingestion; adverse effect; case report; encephalopathy; hyperammonemia; infant; valproic acid

Year:  2021        PMID: 33603587      PMCID: PMC7887879          DOI: 10.5863/1551-6776-26.2.210

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN: 1551-6776


  18 in total

1.  The consequences of valproate overdose.

Authors:  Andrew S Davison; Anna M Milan; Norman B Roberts
Journal:  Clin Chem       Date:  2011-09       Impact factor: 8.327

2.  Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy.

Authors:  David G Vossler; Alan J Wilensky; David F Cawthon; Diana L Abson Kraemer; Linda M Ojemann; Lisa M Caylor; John D Morgan
Journal:  Epilepsia       Date:  2002-02       Impact factor: 5.864

3.  [Acute sodium valproate poisoning].

Authors:  R Garnier; E Fournier
Journal:  Nouv Presse Med       Date:  1982-02-27

4.  Valproic acid induced encephalopathy--19 new cases in Germany from 1994 to 2003--a side effect associated to VPA-therapy not only in young children.

Authors:  Thorsten Gerstner; Deike Buesing; Elke Longin; Claudia Bendl; Dieter Wenzel; Brigitte Scheid; Gisela Goetze; Alfons Macke; Gerhard Lippert; Wolfgang Klostermann; Geert Mayer; Regine Augspach-Hofmann; Sabine Fitzek; Carl-Albrecht Haensch; Markus Reuland; Stephan A Koenig
Journal:  Seizure       Date:  2006-06-19       Impact factor: 3.184

5.  Acute hyperammonemic coma with chronic valproic acid therapy.

Authors:  Miroslav Cuturic; Ruth K Abramson
Journal:  Ann Pharmacother       Date:  2005-11-15       Impact factor: 3.154

6.  Risk factors for valproic acid induced hyperammonemia and its association with cognitive functions.

Authors:  Berker Duman; Kazım Cihan Can; Ece Ağtaş-Ertan; Seyda Erdoğan; Rıfat Serav İlhan; Özlem Doğan; Hakan Kumbasar; Ulaş Mehmet Çamsarı
Journal:  Gen Hosp Psychiatry       Date:  2019-05-31       Impact factor: 3.238

7.  Hemodialysis and hemoperfusion for treatment of valproic acid and gabapentin poisoning.

Authors:  M C Fernandez; F G Walter; J C Kloster; S M Do; L A Brady; A Villarin; S J Ruffenach; E H Prosnitz; J V Salmon
Journal:  Vet Hum Toxicol       Date:  1996-12

Review 8.  Valproic acid poisoning: an evidence-based consensus guideline for out-of-hospital management.

Authors:  Anthony S Manoguerra; Andrew R Erdman; Alan D Woolf; Peter A Chyka; E Martin Caravati; Elizabeth J Scharman; Lisa L Booze; Gwenn Christianson; Lewis S Nelson; Daniel J Cobaugh; William G Troutman
Journal:  Clin Toxicol (Phila)       Date:  2008-08       Impact factor: 4.467

Review 9.  Valproate-induced hyperammonemic encephalopathy: a brief review.

Authors:  Chandani Lewis; Abhishek Deshpande; George E Tesar; Roman Dale
Journal:  Curr Med Res Opin       Date:  2012-06-06       Impact factor: 2.580

Review 10.  Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?

Authors:  Philippe E R Lheureux; Andrea Penaloza; Soheil Zahir; Mireille Gris
Journal:  Crit Care       Date:  2005-06-10       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.